Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone therapy increases bone density in older men with low testosterone levels.

Balding men had lower bone density, while balding women had higher hip bone density.

High hair calcium levels are linked to low calcium intake and low bone density.

Patients treated with long-term intralesional corticosteroids for alopecia areata should be monitored for bone density changes and advised on osteoporosis prevention.

The consensus provided guidelines for treating the Female Athlete Triad and a system to decide when athletes can return to sports.

Researchers created a mouse model for Cushing's syndrome to study glucocorticoid excess and potential treatments.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

Testosterone therapy seems safe for short-term use in postmenopausal women with low sexual desire, but more research on long-term effects is needed.

Testosterone and its metabolites have varied effects on different body systems, especially during puberty.

Collagen with calcium and vitamin D improves bone health, skin elasticity, and reduces hair loss in menopausal women.

Testosterone plus finasteride increases bone density in men with spinal cord injuries.

Testosterone therapy can help improve sexual function, mood, and bone density in women with low androgen levels, but more research is needed on long-term safety.

Women with hyperandrogenic amenorrhea have similar bone density to healthy women but lower than androgenized women without amenorrhea, and high DHEAS levels might affect bone density.

Women with PCOS have similar bone density to healthy women, but those who are obese have higher bone density at some body sites.

Testosterone treatment effectively causes male physical development in transgender male adolescents but may lead to side effects like acne, higher BMI and blood pressure, lower good cholesterol, and decreased bone density.

Dutasteride and finasteride do not significantly affect bone density, blood fats, or blood production, but slightly lower PSA levels and minimally impact sexual function in healthy young men.

Finasteride doesn't harm bone density in older men with BPH.

Women with early-onset baldness should be checked for early bone loss, but bone density doesn't change with baldness severity.

Future osteoporosis treatments should focus on increasing bone growth, with many promising options available.

People with hidradenitis suppurativa often have lower vitamin D levels, weaker hip bones, and altered bone metabolism markers.

Mice with CBS deficiency are healthier on a low-methionine diet.

Androgen therapy might help some women with low libido, but it has risks and should be used carefully.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

Androgen therapy can help with symptoms like low libido in women, but more research is needed to understand its long-term safety and effects on health.

Certain ESR1 gene variations may affect hormone levels and fat distribution in women with high male hormone levels.

Androgen deprivation therapy for prostate cancer can cause sexual, physical, and psychological side effects, and doctors should manage these carefully.

Male pattern baldness is mostly inherited, involves many genes, and is linked to other traits like early puberty and strong bones.

Testosterone replacement may help post-menopausal women with androgen insufficiency, but more research is needed on its benefits and risks.

New male hormonal contraceptives show promise but need more research on long-term effects and funding for larger trials.

Methionine restriction works better than betaine for treating CBS deficiency symptoms in mice.